News - Page 212 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Post published:February 2, 2021
Post category:Press Release

Read more about the article BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder

BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder

Post published:February 2, 2021
Post category:Press Release

Read more about the article PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.

PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.

Post published:February 2, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments

Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments

Post published:February 2, 2021
Post category:Press Release

Read more about the article MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics

MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics

Post published:February 2, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board

Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board

Post published:February 2, 2021
Post category:Press Release

Read more about the article Red Light Holland Announces the Red Light Holland “Give-You-A-Job” Contest

Red Light Holland Announces the Red Light Holland “Give-You-A-Job” Contest

Post published:February 1, 2021
Post category:Press Release

Read more about the article PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine

Post published:February 1, 2021
Post category:Press Release

Read more about the article Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies

Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies

Post published:February 1, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange

Post published:February 1, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.